Business ❯ Pharmaceutical Industry

Market Trends

Drug Pricing Pricing Strategies Drug Development Stock Performance Sales Performance Generic Drugs Weight Loss Drugs Drug Sales Novo Nordisk Product Launches

Wall Street Unanimously Bullish on Teva as Austedo Fuels Turnaround

Analysts say rising Austedo sales alongside Teva's move into branded drugs could lift the stock if the company sustains execution.

FDA Advisers Narrowly Recommend Allowing Six Unapproved Peptides for Compounding

Lilly Will Seek FDA Approval for Retatrutide in Q1 2027 After Two More Positive Phase 3 Trials

Ipsen Says Dysport Met Phase 3 Endpoints for Episodic and Chronic Migraine

Brazilian-Made Semaglutide Pen Ozivy Now on Sale

Osaka Police Refer Three Over Illegal Social‑media Sales of Eli Lilly’s Manjaro

Oral GLP‑1 Approval and New Trials Push Weight‑Loss Drugs Into Mass Market

Lilly’s Experimental Triple-Agonist Retatrutida Produces Weight Loss Comparable to Bariatric Surgery in Phase 3

Argentina's Congress Clears 'Ley Hojarasca' for Senate Vote

Mounjaro Overtakes Keytruda as World’s Best-Selling Drug in Q1 2026

DOJ Moves State-Licensed Medical Marijuana to Schedule III Ahead of June DEA Hearing

Gurugram Bust Seizes 242 Suspected Fake Mounjaro Pens, Two Arrested

India’s ‘Mounjaro Bride’ Trend Fuels Pre‑Wedding Use of GLP‑1 Weight‑Loss Shots

Spyre Drug Meets Midstage Target in Ulcerative Colitis, Stock Rallies

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Amazon Pharmacy Launches Same-Day Delivery for Lilly’s Foundayo Weight-Loss Pill

FDA Grants Accelerated Approval to Lilly’s Oral Weight-Loss Pill Foundayo

Generics Flood India After Semaglutide Patent Lapses, Slashing Prices Up to 90%

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

Brazil's Semaglutide Patent Expires Friday, Opening Door to Ozempic Generics